DJIA 15,303.10 8.60 0.06%
NASDAQ 3,459.14 -0.28 -0.01%
S&P 500 1,649.60 -0.91 -0.06%

GlaxoSmithKline

NYSE: GSK

52.97 0.24 (0.46%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

GSK $52.97 0.46%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $52.42
Previous Close $52.73
Daily Range $52.38 - $53.07
52-Week Range $41.68 - $53.45
Market Cap $143.0B
P/E Ratio 15.88
Dividend (Yield) $2.20 (4.5%)
Ex-Dividend Date
Dividend Pay Date
05/08/13
07/11/13
Volume 1,283,412
Average Daily Volume 3,022,413
Current FY EPS $3.64

Sector

Healthcare

Industry

Drugs

GlaxoSmithKline (GSK) Description

The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products. Website: http://www.gsk.com/

News & Commentary

Stalled Progress in the Fight Against HIV?

Another HIV vaccine bites the dust. Has progress in the fight against HIV stalled?

Elan Rejects Royalty Offer Again - Analyst Blog

Impax Launches Generic Zomig - Analyst Blog

Data on UCB's Neupro - Analyst Blog

Data on UCB's Neupro - Analyst Blog

XenoPort Resumes Horizant Supply - Analyst Blog

U.S. Gives Glaxo Up To $200 Million for Antibiotic Research

3 Reasons to Love GlaxoSmithKline

Do these three things make GlaxoSmithKline a good investment?

The 5 Highest-Paying Dividend Stocks in Big Pharma

Not all top dividend yields are backed up by strong businesses.

Toll Reports Better-than-Expected Earnings: Ahead of the Ticker

GlaxoSmithKline Awarded Up to $200 Million by US to Develop New Antibiotics

See More GSK News...

GSK's Top Competitors

GSK $52.97 (0.46%)
Current stock: GSK
JNJ $86.82 (-0.45%)
Current stock: JNJ
NVS $74.36 (0.73%)
Current stock: NVS
RHHBY $65.96 (0.61%)
Current stock: RHHBY